Affiliation:
1. Laboratory of Molecular Immunology, The Rockefeller University, New York, NY
2. Howard Hughes Medical Institute, The Rockefeller University, New York, NY
Abstract
HIV-1 infection requires lifelong therapy with antiretroviral drugs due to the existence of a latent reservoir of transcriptionally inactive integrated proviruses. The goal of HIV-1 cure research is to eliminate or functionally silence this reservoir. To this end, there are numerous ongoing studies to evaluate immunological approaches, including monoclonal antibody therapies. Evaluating the results of these studies requires sensitive and specific measures of the reservoir. Here, we describe a relatively high-throughput combined quantitative PCR (qPCR) and next-generation sequencing method. Four different qPCR probes covering the packaging signal (PS), group-specific antigen (gag), polymerase (pol), and envelope (env) are combined in a single multiplex reaction to detect the HIV-1 genome in limiting dilution samples followed by sequence verification of individual reactions that are positive for combinations of any two of the four probes (Q4PCR). This sensitive and specific approach allows for an unbiased characterization of the HIV-1 latent reservoir.
Funder
National Center for Advancing Translational Sciences
National Institutes of Health
Shapiro-Silverberg Fund
Bill and Melinda Gates Foundation
Einstein–Rockefeller–CUNY Center for AIDS Research
BEAT-HIV Delaney
Robertson Fund
Howard Hughes Medical Institute
Robert S. Wennett Post-Doctoral Fellowship
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献